glp 1 masld Role of glucagon-like peptide-1 receptor agonists in pediatric obesity and metabolic dysfunction associated steatotic liver disease The Emerging Role of Glucagon-Like

Document side effects and their severity so you can discuss trends with your provider

It is noteworthy that although GLP-1 and insulin combination therapy may provide convenience in practice, combination therapy comes at the cost of diminished dosing flexibility of both drugs, raising concerns about whether the specific combination therapy actually achieves better therapeutic efficacy than two drugs that are titrated separately

Patients taking GLP-1 medications with insulin or sulfonylureas have an increased risk of hypoglycemia and should discuss timing of all medications with their healthcare provider to minimize this risk

What are the potential side effects of GLP-1 agonists

Serious Risks Rare but important: Pancreatitis: Occurs in a small percentage of patients